MAXLINEAR INC (MXL)

US57776J1007 - Common Stock

20.47  -0.14 (-0.68%)

After market: 20.55 +0.08 (+0.39%)

Fundamental Rating

2

Overall MXL gets a fundamental rating of 2 out of 10. We evaluated MXL against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. MXL has a bad profitability rating. Also its financial health evaluation is rather negative. MXL has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year MXL has reported negative net income.
MXL had a negative operating cash flow in the past year.
In multiple years MXL reported negative net income over the last 5 years.
Each year in the past 5 years MXL had a positive operating cash flow.

1.2 Ratios

MXL has a worse Return On Assets (-25.23%) than 82.24% of its industry peers.
MXL's Return On Equity of -40.56% is on the low side compared to the rest of the industry. MXL is outperformed by 80.37% of its industry peers.
Industry RankSector Rank
ROA -25.23%
ROE -40.56%
ROIC N/A
ROA(3y)2.61%
ROA(5y)-0.93%
ROE(3y)5.47%
ROE(5y)-2.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MXL's Gross Margin of 53.86% is fine compared to the rest of the industry. MXL outperforms 71.96% of its industry peers.
MXL's Gross Margin has been stable in the last couple of years.
MXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.75%
GM growth 5Y0.51%

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
MXL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MXL has been increased compared to 5 years ago.
Compared to 1 year ago, MXL has a worse debt to assets ratio.

2.2 Solvency

MXL has an Altman-Z score of 2.66. This is not the best score and indicates that MXL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.66, MXL is doing worse than 60.75% of the companies in the same industry.
A Debt/Equity ratio of 0.22 indicates that MXL is not too dependend on debt financing.
The Debt to Equity ratio of MXL (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.66
ROIC/WACCN/A
WACC14.45%

2.3 Liquidity

A Current Ratio of 1.95 indicates that MXL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.95, MXL is not doing good in the industry: 73.83% of the companies in the same industry are doing better.
A Quick Ratio of 1.38 indicates that MXL should not have too much problems paying its short term obligations.
The Quick ratio of MXL (1.38) is worse than 73.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.38

3

3. Growth

3.1 Past

MXL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -137.33%.
MXL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.18% yearly.
MXL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.14%.
MXL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.48% yearly.
EPS 1Y (TTM)-137.33%
EPS 3Y8.46%
EPS 5Y0.18%
EPS Q2Q%-1900%
Revenue 1Y (TTM)-54.14%
Revenue growth 3Y13.15%
Revenue growth 5Y12.48%
Sales Q2Q%-40.16%

3.2 Future

MXL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.49% yearly.
The Revenue is expected to decrease by -3.19% on average over the next years.
EPS Next Y-185.81%
EPS Next 2Y-43.41%
EPS Next 3Y-0.39%
EPS Next 5Y4.49%
Revenue Next Year-48.26%
Revenue Next 2Y-19.86%
Revenue Next 3Y-6.98%
Revenue Next 5Y-3.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

MXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 57.58, the valuation of MXL can be described as expensive.
MXL's Price/Forward Earnings ratio is in line with the industry average.
MXL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.67.
Industry RankSector Rank
PE N/A
Fwd PE 57.58

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.41%
EPS Next 3Y-0.39%

0

5. Dividend

5.1 Amount

MXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAXLINEAR INC

NASDAQ:MXL (1/6/2025, 5:24:29 PM)

After market: 20.55 +0.08 (+0.39%)

20.47

-0.14 (-0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-23 2024-10-23/amc
Earnings (Next)01-29 2025-01-29/amc
Inst Owners87.72%
Inst Owner Change0%
Ins Owners5.72%
Ins Owner Change-1.42%
Market Cap1.73B
Analysts72.5
Price Target20.5 (0.15%)
Short Float %5.57%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.77%
Min EPS beat(2)-27.3%
Max EPS beat(2)-10.24%
EPS beat(4)2
Avg EPS beat(4)-1.52%
Min EPS beat(4)-27.3%
Max EPS beat(4)27.26%
EPS beat(8)4
Avg EPS beat(8)-5.98%
EPS beat(12)8
Avg EPS beat(12)-2.35%
EPS beat(16)12
Avg EPS beat(16)0.24%
Revenue beat(2)1
Avg Revenue beat(2)-4.21%
Min Revenue beat(2)-8.96%
Max Revenue beat(2)0.54%
Revenue beat(4)2
Avg Revenue beat(4)-2.2%
Min Revenue beat(4)-8.96%
Max Revenue beat(4)0.54%
Revenue beat(8)2
Avg Revenue beat(8)-2.4%
Revenue beat(12)4
Avg Revenue beat(12)-1.67%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)-0.06%
PT rev (3m)-5.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-311.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 57.58
P/S 4.39
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 9.58
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)0.36
Fwd EY1.74%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS4.67
BVpS6.6
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.23%
ROE -40.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.86%
FCFM N/A
ROA(3y)2.61%
ROA(5y)-0.93%
ROE(3y)5.47%
ROE(5y)-2.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.75%
GM growth 5Y0.51%
F-Score1
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.66%
Cap/Sales 5.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.38
Altman-Z 2.66
F-Score1
WACC14.45%
ROIC/WACCN/A
Cap/Depr(3y)68.6%
Cap/Depr(5y)47.27%
Cap/Sales(3y)6.39%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.33%
EPS 3Y8.46%
EPS 5Y0.18%
EPS Q2Q%-1900%
EPS Next Y-185.81%
EPS Next 2Y-43.41%
EPS Next 3Y-0.39%
EPS Next 5Y4.49%
Revenue 1Y (TTM)-54.14%
Revenue growth 3Y13.15%
Revenue growth 5Y12.48%
Sales Q2Q%-40.16%
Revenue Next Year-48.26%
Revenue Next 2Y-19.86%
Revenue Next 3Y-6.98%
Revenue Next 5Y-3.19%
EBIT growth 1Y-368.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-140.92%
EBIT Next 3Y8.36%
EBIT Next 5YN/A
FCF growth 1Y-120.15%
FCF growth 3Y-44%
FCF growth 5Y-35.94%
OCF growth 1Y-110.15%
OCF growth 3Y-16.16%
OCF growth 5Y-15.84%